Fibrocell Develops FCX-013 Investigational Gene Therapy for Treatment of Linear Scleroderma – Scleroderma News
Scleroderma NewsFibrocell Develops FCX-013 Investigational Gene Therapy for Treatment of Linear SclerodermaScleroderma NewsFibrocell Science of Exton, Pa., recently started a preclinical dose-ranging study for FCX-013, an investigational drug to treat … Continue reading
